Tag Archives: Federal Circuit

Top Ten List of Patent News Stories in 2018

Although this list will reach most the readers of Patents4Life after 2019 begins, 2018 deserves some attention even if it has the feel of “those we lost in 2018” lists. Although most of my colleague-commentators have published their lists by … Continue reading

Posted in 2018 Patent News, Section 101 | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Legal Wiggle Room in the Joint AIPLA-IPO Proposal on Patentability?

I recently took another look at the Joint AIPLA-IPO Proposal on Patent Eligibility that was prompted by the scheduling of a discussion meeting by the Minnesota Intellectual Property Law Association. I confess that I did not participate in either the … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Life Science Patenting to Iancu – “We need help too!”

In his remarks presented at the recent 10th Annual Patent Law & Policy Conference at Georgetown University Law School, USPTO Director Andrei Iancu outlined the analytical framework for the new, eagerly awaited, PTO Guidance on patent eligible subject matter. Although … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , | Leave a comment

Kumar v. Iancu – The Dangers of an Overstuffed Preamble/Note on 37 CFR Part 4.

On November 7, 2018, the Fed. Cir. issued a summary affirmance of the PTAB’s interference decision of September 6, 2016, in Kumar v. Sung (Patent Interference 14/322,039) which found that the claims of U.S. Pat. No. 8,541,422 were obvious over … Continue reading

Posted in Obviousness | Tagged , , , , , , , , | Leave a comment